424 related articles for article (PubMed ID: 20426780)
1. Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodes.
von Felbert V; Hoffmann G; Hoff-Lesch S; Abuzahra F; Renn CN; Braathen LR; Merk HF
Br J Dermatol; 2010 Sep; 163(3):607-15. PubMed ID: 20426780
[TBL] [Abstract][Full Text] [Related]
2. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Lacour JP; Ulrich C; Gilaberte Y; Von Felbert V; Basset-Seguin N; Dreno B; Girard C; Redondo P; Serra-Guillen C; Synnerstad I; Tarstedt M; Tsianakas A; Venema AW; Kelleners-Smeets N; Adamski H; Perez-Garcia B; Gerritsen MJ; Leclerc S; Kerrouche N; Szeimies RM
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2342-8. PubMed ID: 26435363
[TBL] [Abstract][Full Text] [Related]
3. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
Togsverd-Bo K; Haak CS; Thaysen-Petersen D; Wulf HC; Anderson RR; Hædersdal M
Br J Dermatol; 2012 Jun; 166(6):1262-9. PubMed ID: 22348388
[TBL] [Abstract][Full Text] [Related]
4. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P;
Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.
Zane C; Facchinetti E; Rossi MT; Specchia C; Calzavara-Pinton PG
Br J Dermatol; 2014 May; 170(5):1143-50. PubMed ID: 24506666
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of photodynamic therapy of actinic keratosis comparing different red light sources.
Giehl KA; Kriz M; Grahovac M; Ruzicka T; Berking C
Eur J Dermatol; 2014; 24(3):335-41. PubMed ID: 24876164
[TBL] [Abstract][Full Text] [Related]
8. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
Neittaanmäki-Perttu N; Karppinen TT; Grönroos M; Tani TT; Snellman E
Br J Dermatol; 2014 Nov; 171(5):1172-80. PubMed ID: 25109244
[TBL] [Abstract][Full Text] [Related]
9. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
[TBL] [Abstract][Full Text] [Related]
10. Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
Gutiérrez García-Rodrigo C; Pellegrini C; Piccioni A; Tambone S; Fargnoli MC
Photodiagnosis Photodyn Ther; 2019 Sep; 27():100-104. PubMed ID: 31141730
[TBL] [Abstract][Full Text] [Related]
11. Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study.
Ko DY; Jeon SY; Kim KH; Song KH
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1529-39. PubMed ID: 24341367
[TBL] [Abstract][Full Text] [Related]
12. Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study.
Szeimies RM; Matheson RT; Davis SA; Bhatia AC; Frambach Y; Klövekorn W; Fesq H; Berking C; Reifenberger J; Thaçi D
Dermatol Surg; 2009 Apr; 35(4):586-92. PubMed ID: 19309347
[TBL] [Abstract][Full Text] [Related]
13. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC
Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318
[TBL] [Abstract][Full Text] [Related]
14. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities.
Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE
Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid.
Kasche A; Luderschmidt S; Ring J; Hein R
J Drugs Dermatol; 2006 Apr; 5(4):353-6. PubMed ID: 16673803
[TBL] [Abstract][Full Text] [Related]
16. 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.
Räsänen JE; Neittaanmäki N; Ylitalo L; Hagman J; Rissanen P; Ylianttila L; Salmivuori M; Snellman E; Grönroos M
Br J Dermatol; 2019 Aug; 181(2):265-274. PubMed ID: 30329163
[TBL] [Abstract][Full Text] [Related]
17. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Fargnoli MC; Piccioni A; Neri L; Tambone S; Pellegrini C; Peris K
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1926-32. PubMed ID: 25809617
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
Wiegell SR; Haedersdal M; Eriksen P; Wulf HC
Br J Dermatol; 2009 Jun; 160(6):1308-14. PubMed ID: 19416257
[TBL] [Abstract][Full Text] [Related]
19. A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.
Wiegell SR; Fabricius S; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Jemec GB; Mogensen M; Brocks KM; Philipsen PA; Heydenreich J; Haedersdal M; Wulf HC
Br J Dermatol; 2011 May; 164(5):1083-90. PubMed ID: 21219287
[TBL] [Abstract][Full Text] [Related]
20. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
